Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-23-007051

Chief Development Officer acquired 2,944 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Guyer William · Chief Development Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-01 Grant or award : show line 1 in the form +1,472 $19.86 $29,234 3,316 D
2023-03-01 Grant or award : show line 2 in the form +1,472 4,788 D
Loading xslF345X03/doc4.xml…